Janneke G Langendonk (Janneke Langendonk)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Peritoneal Dialysis

Smoking Cessation

Intensive Care Unit

Hepatitis B Virus

Top Venues

Life (Basel, Switzerland)

The Journal of dermatology

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Louisa G Kluijver, Debby Wensink, Margreet A E M Wagenmakers, Hidde H Huidekoper, Peter Witters, Daisy Rymen, Janneke G Langendonk
Quality of life in children with erythropoietic protoporphyria: a case-control study. The Journal of dermatology 51 (8) (2024)
Anna-Elisabeth Minder, Louisa G Kluijver, Jasmin Barman-Aksözen, Elisabeth I Minder, Janneke G Langendonk
Erythropoietic protoporphyrias: Pathogenesis, diagnosis and management. Liver international : official journal of the International Association for the Study of the Liver (2024)
Louisa G Kluijver, Debby Wensink, Margreet A E M Wagenmakers, Hidde H Huidekoper, Peter Witters, Daisy Rymen, Janneke G Langendonk
Quality of life in children with erythropoietic protoporphyria: a case-control study. The Journal of dermatology (2024)
Debby Wensink, Margreet A E M Wagenmakers, J H Paul Wilson, Janneke G Langendonk
Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotide. The Journal of dermatology (2022)
Loek L Crefcoeur, Mireille C Melles, Tobias A Bruning, Rob Rodrigues Pereira, Janneke G Langendonk
Primary carnitine deficiency is a life-long disease. JIMD reports 63 (6) (2022)
Rochus A Neeleman, Kyra Musters, Margreet A E M Wagenmakers, Gerritje Sophie Mijnhout, Edith Friesema, Eric Sijbrands, Janneke G Langendonk
Mortality in Pedigrees with Acute Intermittent Porphyria. Life (Basel, Switzerland) 12 (12) (2022)
Rochus A Neeleman, Kyra Musters, Margreet A E M Wagenmakers, Gerritje Sophie Mijnhout, Edith Friesema, Eric Sijbrands, Janneke G Langendonk
Mortality in Pedigrees with Acute Intermittent Porphyria. Life (Basel, Switzerland) 12 (12) (2022)
Rochus A Neeleman, Kyra Musters, Margreet A E M Wagenmakers, Gerritje Sophie Mijnhout, Edith Friesema, Eric Sijbrands, Janneke G Langendonk
Mortality in Pedigrees with Acute Intermittent Porphyria. Life (Basel, Switzerland) 12 (12) (2022)
Rochus A Neeleman, Kyra Musters, Margreet A E M Wagenmakers, Gerritje Sophie Mijnhout, Edith Friesema, Eric Sijbrands, Janneke G Langendonk
Mortality in Pedigrees with Acute Intermittent Porphyria. Life (Basel, Switzerland) 12 (12) (2022)
Debby Wensink, Margreet A E M Wagenmakers, Janneke G Langendonk
Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria. Expert review of clinical pharmacology 14 (2) (2021)
Femke Molema, Monique Williams, Janneke G Langendonk, Sarwa Darwish-Murad, Jacqueline van de Wetering, Ed Jacobs, Willem Onkenhout, Esther Brusse, Anke van der Eerden, Margreet A E M Wagenmakers
Neurotoxicity including posterior reversible encephalopathy syndrome after initiation of calcineurin inhibitors in transplanted methylmalonic acidemia patients: Two case reports and review of the literature. JIMD reports 51 (1) (2020)
Rochus A Neeleman, J H Paul Wilson, Monique Williams, Janneke G Langendonk
Heme as an initial treatment for severe decompensation in tyrosinemia type 1. Genetics in medicine : official journal of the American College of Medical Genetics 22 (2) (2019)